Involuntary hospitalization of first-episode psychosis with substance abuse during a 2-year follow-up

Acta Psychiatrica Scandinavica

Volumn 124, Issue 3, 2011, Pages 198-204

  Opsal, A ^a   Clausen, T ^a,b   Kristensen, O ^a   Elvik, I ^c   Joa, I ^c   Larsen, T K ^c  

^a Sørlandet Hospital   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c STAVANGER UNIVERSITY HOSPITAL   (Norway)

Author keywords

Comorbidity; Early detection; First episode psychosis; Follow up; Involuntary hospitalization; Substance abuse

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CLINICIAN RATING SCALE; DIAGNOSTIC VALUE; DISEASE DURATION; FEMALE; FIRST EPISODE PSYCHOSIS; FOLLOW UP; GLOBAL ASSESMENT OF FUNCTIONING; HOSPITALIZATION; HUMAN; INVOLUNTARY COMMITMENT; MAJOR CLINICAL STUDY; MALE; POSITIVE AND NEGATIVE SYNDROME SCALE; PRIORITY JOURNAL; PSYCHOSIS; SEMI STRUCTURED INTERVIEW; SUBSTANCE ABUSE; TREATMENT OUTCOME; TREATMENT RESPONSE;

ACTIVITIES OF DAILY LIVING; ADOLESCENT; ADULT; COMMITMENT OF MENTALLY ILL; COMORBIDITY; EARLY MEDICAL INTERVENTION; EPISODE OF CARE; FEMALE; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; MALE; MENTALLY ILL PERSONS; PATIENT DROPOUTS; PREVALENCE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOTIC DISORDERS; RISK FACTORS; SUBSTANCE-RELATED DISORDERS;

EID: 80051668958     PISSN: 0001690X     EISSN: 16000447     Source Type: Journal    
DOI: 10.1111/j.1600-0447.2011.01700.x     Document Type: Article

References (42)

1. Menezes NM, Malla AM, Norman RM, Archie S, Roy P, Zipursky RB. A multi-site Canadian perspective: examining the functional outcome from first-episode psychosis. Acta Psychiatr Scand 2009;120:138-146.
2. Larsen TK, Melle I, Auestad B et al. Substance abuse in first-episode non-affective psychosis. Schizophr Res 2006;88:55-62.
3. Turkington A, Mulholland CC, Rushe TM et al. Impact of persistent substance misuse on 1-year outcome in first-episode psychosis. Br J Psychiatry 2009;195:242-248.
4. Maniglio R. Severe mental illness and criminal victimization: a systematic review. Acta Psychiatr Scand 2009;119:180-191.
5. Wallace C, Mullen PE, Burgess P. Criminal offending in schizophrenia over a 25-year period marked by deinstitutionalization and increasing prevalence of comorbid substance use disorders. Am J Psychiatry 2004;161:716-727.
6. Addington J, Williams J, Young J, Addington D. Suicidal behaviour in early psychosis. Acta Psychiatr Scand 2004;109:116-120.
7. Ruschena D, Mullen PE, Burgess P et al. Sudden death in psychiatric patients. Br J Psychiatry 1998;172:331-336.
8. Barrett EA, Sundet K, Faerden A et al. Suicidality before and in the early phases of first episode psychosis. Schizophr Res 2010;119:11-17.
9. Buhler B, Hambrecht M, Loffler W, An Der Heiden W, Hafner H. Precipitation and determination of the onset and course of schizophrenia by substance abuse - a retrospective and prospective study of 232 population-based first illness episodes. Schizophr Res 2002;54:243-251.
10. Stirling J, Lewis S, Hopkins R, White C. Cannabis use prior to first onset psychosis predicts spared neurocognition at 10-year follow-up. Schizophr Res 2005;75:135-137.
11. Carey KB, Carey MP, Simons JS. Correlates of substance use disorder among psychiatric outpatients: focus on cognition, social role functioning, and psychiatric status. J Nerv Ment Dis 2003;191:300-308.
12. Iversen KI, Hoyer G, Sexton HC. Rates for civil commitment to psychiatric hospitals in Norway. Are registry data accurate? Nord J Psychiatry 2009;63:301-307.
13. Psykisk helsevernloven (1999). Oslo: Cappelen akademisk forlag, 2009.
14. Salize HJ, Dressing H. Epidemiology of involuntary placement of mentally ill people across the European Union. Br J Psychiatry 2004;184:163-168.
15. Poulsen HD, Olsen CE. Use and registration of coercion in psychiatry in the new millennium. Ugeskr Laeger 2002;164:4664-4667.
16. Kjellin L, Ostman O, Ostman M. Compulsory psychiatric care in Sweden: development 1979-2002 and area variation. Int J Law Psychiatry 2008;31:51-59.
17. Mazzoncini R, Donoghue K, Hart J et al. Illicit substance use and its correlates in first episode psychosis. Acta Psychiatr Scand 2010;121:351-358.
18. Helseth V, Lykke-Enger T, Johnsen J, Waal H. Substance use disorders among psychotic patients admitted to inpatient psychiatric care. Nord J Psychiatry 2009;63:72-77.
19. Archie S, Rush BR, Akhtar-Danesh N et al. Substance use and abuse in first-episode psychosis: prevalence before and after early intervention. Schizophr Bull 2007;33:1354-1363.
20. Addington J, Addington D. Patterns, predictors and impact of substance use in early psychosis: a longitudinal study. Acta Psychiatr Scand 2007;115:304-309.
21. Turner M, Boden J, Smith-Hamel C, Mulder R. Outcomes for 236 patients from a 2-year early intervention in psychosis service. Acta Psychiatr Scand 2009;120:129-137.
22. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, 4th edn, Revised: DSM-IV-TR. Washington, DC: American Psychiatric Association, 2000.
23. Joa I, Johannessen JO, Langeveld J et al. Baseline profiles of adolescent vs. adult-onset first-episode psychosis in an early detection program. Acta Psychiatr Scand 2009;119:494-500.
24. Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987;13:261-276.
25. Bentsen H, Munkvold OG, Notland TH et al. The interrater reliability of the Positive and Negative Syndrome Scale. Int J Methods Psychiatr Res 1996;6:227-235.
26. Pedersen G, Hagtvet KA, Karterud S. Generalizability studies of the Global Assessment of Functioning-Split version. Compr Psychiatry 2007;48:88-94.
27. Joa I, Johannessen JO, Auestad B et al. The key to reducing duration of untreated first psychosis: information campaigns. Schizophr Bull 2008;34:466-472.
28. Mueser KT, Nordsy DL, Drake RE, Fox L. Integrated treatment for dual disorders. New York: The Guildford Press, 2003.
29. Nesvag R, Lange EH, Faerden A et al. The use of screening instruments for detecting alcohol and other drug use disorders in first-episode psychosis. Psychiatry Res 2010;177:228-234.
30. Wade D, Harrigan S, Edwards J, Burgess PM, Whelan G, Mcgorry PD. Substance misuse in first-episode psychosis: 15-month prospective follow-up study. Br J Psychiatry 2006;189:229-234.
31. Koskinen J, Lohonen J, Koponen H, Isohanni M, Miettunen J. Prevalence of alcohol use disorders in schizophrenia - a systematic review and meta-analysis. Acta Psychiatr Scand 2009;120:85-96.
32. Barnes TRE, Mutsatsa SH, Hutton SB, Watt HC, Joyce EM. Comorbid substance use and age at onset of schizophrenia. Br J Psychiatry 2006;188:237-242.
33. Kavanagh DJ, Mcgrath J, Saunders JB, Dore G, Clark D. Substance misuse in patients with schizophrenia: epidemiology and management. Drugs 2002;62:743-755.
34. Koster A, Lajer M, Lindhardt A, Rosenbaum B. Gender differences in first episode psychosis. Soc Psychiatry Psychiatr Epidemiol 2008;43:940-946.
35. Power P, Elkins K, Adlard S, Curry C, Mcgorry P, Harrigan S. Analysis of the initial treatment phase in first-episode psychosis. Br J Psychiatry Suppl 1998;172:71-76.
36. Opjordsmoen S, Friis S, Melle I et al. A 2-year follow-up of involuntary admission's influence upon adherence and outcome in first-episode psychosis. Acta Psychiatr Scand 2010;121:371-376.
37. Flovig JC, Vaaler AE, Morken G. Substance use at admission to an acute psychiatric department. Nord J Psychiatry 2009;63:113-119.
38. Vaaler AE, Morken G, Flovig JC, Iversen VC, Linaker OM. Substance abuse and recovery in a Psychiatric Intensive Care Unit. Gen Hosp Psychiatry 2006;28:65-70.
39. Shaner A, Khalsa ME, Roberts L, Wilkins J, Anglin D, Hsieh SC. Unrecognized cocaine use among schizophrenic patients. Am J Psychiatry 1993;150:758-762.
40. Wilkins JN, Shaner AL, Patterson M, Setoda D, Gorelick D. Discrepancies between patient report, clinical assessment, and urine analysis in psychiatric patients during inpatient admission. Psychopharmacol Bull 1991;27:149-154.
41. Mordal J, Holm B, Morland J, Bramness JG. Recent substance intake among patients admitted to acute psychiatric wards: physician's assessment and on-site urine testing compared with comprehensive laboratory analyses. J Clin Psychopharmacol 2010;30:455-459.
42. De Beaurepaire R, Lukasiewicz M, Beauverie P et al. Comparison of self-reports and biological measures for alcohol, tobacco, and illicit drugs consumption in psychiatric inpatients. Eur Psychiatry 2007;22:540-548.